Index
Reported signs
1,130 coded terms with 200 or more reports, A to Z
Terms are from VeDDRA, the dictionary used to code veterinary adverse event reports, plus legacy FDA terms from older reports. Many describe a product not working as expected or a packaging defect, not illness.
| Term | Plain language | Reports | Share of all reports | Latest 12 months |
|---|---|---|---|---|
| Abdominal cavity disorder NOS | NOS: not otherwise specified | 535 | 0% | 38 |
| Abdominal cavity haemorrhage | 675 | 0.1% | 26 | |
| Abdominal discomfort | 831 | 0.1% | 73 | |
| Abdominal effusion | 480 | 0% | 54 | |
| Abdominal mass | 913 | 0.1% | 66 | |
| Abdominal pain | 6,216 | 0.5% | 153 | |
| Abnormal adrenocorticotropic hormone (ACTH) stimulation test | 949 | 0.1% | 66 | |
| Abnormal breathing | 2,677 | 0.2% | 129 | |
| Abnormal cytology | 2,003 | 0.2% | 393 | |
| Abnormal ECG | 320 | 0% | 0 | |
| Abnormal menace reflex test | 995 | 0.1% | 111 | |
| Abnormal movement NOS | NOS: not otherwise specified | 1,018 | 0.1% | 99 |
| Abnormal posture | 244 | 0% | 42 | |
| Abnormal posture NOS | NOS: not otherwise specified | 2,889 | 0.2% | 171 |
| Abnormal pupil light reflex | 970 | 0.1% | 73 | |
| Abnormal radiograph finding | 9,990 | 0.7% | 787 | |
| Abnormal red blood cell | 456 | 0% | 21 | |
| Abnormal stool colouration | 1,099 | 0.1% | 57 | |
| Abnormal test result | 377 | 0% | 0 | |
| Abnormal ultrasound finding | 6,192 | 0.5% | 401 | |
| Abnormal urine odour | 424 | 0% | 16 | |
| Abortion | 899 | 0.1% | 12 | |
| Abscess NOS | NOS: not otherwise specified | 475 | 0% | 44 |
| Accidental drug intake by child | 345 | 0% | 2 | |
| Accidental exposure | exposure that was not intended | 31,044 | 2.3% | 830 |
| Acidic urine | 218 | 0% | 28 | |
| Acidosis | 324 | 0% | 34 | |
| Active urine sediment | 202 | 0% | 23 | |
| Acute renal failure | 651 | 0.1% | 45 | |
| Addison's disease | 316 | 0% | 17 | |
| Adipsia | not drinking | 5,028 | 0.4% | 83 |
| Administration device NOS, abnormal | 207 | 0% | 76 | |
| Administration device NOS, malfunction | 367 | 0% | 40 | |
| Administration error NOS | NOS: not otherwise specified | 1,428 | 0.1% | 654 |
| Adrenal gland disorder NOS | NOS: not otherwise specified | 576 | 0% | 47 |
| Aggression | 5,589 | 0.4% | 265 | |
| Agitation | 5,779 | 0.4% | 267 | |
| Alkaline urine | 607 | 0% | 60 | |
| Allergic dermatitis | 416 | 0% | 34 | |
| Allergic pruritus | 374 | 0% | 14 | |
| Allergic reaction | 1,527 | 0.1% | 91 | |
| Allergic skin reaction | 249 | 0% | 12 | |
| Allergy NOS | NOS: not otherwise specified | 1,160 | 0.1% | 89 |
| Alopecia | hair loss | 1,800 | 0.1% | 120 |
| Alopecia general | 390 | 0% | 16 | |
| Alopecia local | 1,379 | 0.1% | 117 | |
| Alopecia NOS | hair loss, type not specified | 4,252 | 0.3% | 30 |
| Alteration of milk quality | 867 | 0.1% | 2 | |
| Anaemia NOS | low red blood cell count | 12,844 | 1% | 579 |
| Anal irritation | 300 | 0% | 7 | |
| Anal sac disorder | 560 | 0% | 40 | |
| Anaphylactic shock | 302 | 0% | 20 | |
| Anaphylactic-type reaction | 1,144 | 0.1% | 33 | |
| Anaphylactoid reaction | sudden allergic-type reaction | 2,318 | 0.2% | 18 |
| Anaphylaxis | sudden severe allergic-type reaction | 11,300 | 0.8% | 523 |
| Anisocoria | 992 | 0.1% | 58 | |
| Anorexia | not eating | 59,480 | 4.4% | 1,257 |
| Anuria | 729 | 0.1% | 32 | |
| Anxiety | 5,638 | 0.4% | 459 | |
| Apathy | 257 | 0% | 8 | |
| Apnoea | breathing stopped | 2,653 | 0.2% | 46 |
| Appearance, Abnormal | a product quality report, not a sign in an animal | 4,723 | 0.4% | 375 |
| Appetite disorder NOS | NOS: not otherwise specified | 468 | 0% | 58 |
| Appetite loss | 3,275 | 0.2% | 279 | |
| Application site alopecia | hair loss where the product was applied | 10,078 | 0.7% | 222 |
| Application site bleeding | bleeding where the product was applied | 535 | 0% | 56 |
| Application site blister | blister where the product was applied | 360 | 0% | 32 |
| Application site burn | burn where the product was applied | 910 | 0.1% | 85 |
| Application site crust | crust where the product was applied | 532 | 0% | 42 |
| Application site dermatitis | inflamed skin where the product was applied | 290 | 0% | 18 |
| Application site erythema | reddened skin where the product was applied | 3,518 | 0.3% | 121 |
| Application site greasy fur | greasy fur where the product was applied | 448 | 0% | 36 |
| Application site hair change | hair change where the product was applied | 907 | 0.1% | 29 |
| Application site hair coat discolouration | hair coat discolouration where the product was applied | 207 | 0% | 17 |
| Application site hair loss | hair loss where the product was applied | 8,118 | 0.6% | 769 |
| Application site inflammation | inflammation where the product was applied | 1,984 | 0.2% | 89 |
| Application site irritation | irritation where the product was applied | 1,928 | 0.1% | 186 |
| Application site itching | itching where the product was applied | 797 | 0.1% | 97 |
| Application site lesion | lesion where the product was applied | 2,682 | 0.2% | 87 |
| Application site pain | pain where the product was applied | 1,014 | 0.1% | 94 |
| Application site pruritus | itching where the product was applied | 2,717 | 0.2% | 62 |
| Application site rash | rash where the product was applied | 368 | 0% | 37 |
| Application site reaction NOS | reaction nos where the product was applied | 1,253 | 0.1% | 53 |
| Application site reddening | reddening where the product was applied | 2,119 | 0.2% | 286 |
| Application site residue | residue where the product was applied | 543 | 0% | 42 |
| Application site scab | scab where the product was applied | 2,649 | 0.2% | 229 |
| Application site scratching | scratching where the product was applied | 1,109 | 0.1% | 112 |
| Application site self trauma | self trauma where the product was applied | 227 | 0% | 18 |
| Application site skin change NOS | skin change nos where the product was applied | 720 | 0.1% | 11 |
| Application site skin scaling | skin scaling where the product was applied | 209 | 0% | 27 |
| Application site sore | sore where the product was applied | 390 | 0% | 32 |
| Application site stickiness | stickiness where the product was applied | 502 | 0% | 75 |
| Application site swelling | swelling where the product was applied | 1,261 | 0.1% | 36 |
| Application site ulcer | ulcer where the product was applied | 506 | 0% | 34 |
| Applicator, Abnormal | a product quality report, not a sign in an animal | 626 | 0.1% | 22 |
| Apprehension | 1,666 | 0.1% | 3 | |
| Arched back | 449 | 0% | 47 | |
| Arrhythmia | 1,382 | 0.1% | 58 | |
| Arthritis | 1,711 | 0.1% | 219 | |
| Ascites | fluid in the abdomen | 1,749 | 0.1% | 33 |
| Aspiration pneumonia | 214 | 0% | 64 | |
| Ataxia | unsteady, uncoordinated movement | 31,905 | 2.4% | 1,511 |
| Atopic allergy NOS | NOS: not otherwise specified | 283 | 0% | 22 |
| Attention-seeking behaviour | 262 | 0% | 33 | |
| Aural haematoma | 240 | 0% | 36 | |
| Autoimmune disorder NOS | NOS: not otherwise specified | 539 | 0% | 24 |
| Azotaemia | raised kidney values in blood | 2,451 | 0.2% | 174 |
| Bacterial skin infection NOS | NOS: not otherwise specified | 1,483 | 0.1% | 126 |
| Bad taste | 281 | 0% | 17 | |
| Balance impaired | 725 | 0.1% | 94 | |
| Balance problem | 1,693 | 0.1% | 115 | |
| Bands(neutrophils) high, blood | 556 | 0% | 0 | |
| Barking | 527 | 0% | 68 | |
| Basophilia | 457 | 0% | 56 | |
| Behavioural disorder NOS | behaviour change, type not specified | 26,442 | 2% | 1,488 |
| Bilirubinuria | 1,542 | 0.1% | 76 | |
| Birth defect | 246 | 0% | 1 | |
| Biting - pruritus | 590 | 0% | 83 | |
| Biting -aggression | 1,272 | 0.1% | 74 | |
| Bladder incontinence | 293 | 0% | 27 | |
| Blepharospasm | 623 | 0.1% | 32 | |
| Blindness | 4,395 | 0.3% | 181 | |
| Blinking | 237 | 0% | 19 | |
| Blistering | 345 | 0% | 24 | |
| Bloated | 505 | 0% | 46 | |
| Bloated stomach | 283 | 0% | 27 | |
| Blood and lymphatic system disorder NOS | NOS: not otherwise specified | 556 | 0% | 5 |
| Blood in faeces | 2,322 | 0.2% | 120 | |
| Blood in faeces NOS | NOS: not otherwise specified | 307 | 0% | 0 |
| Blood in urine | 1,974 | 0.2% | 195 | |
| Blood in vomit | 4,896 | 0.4% | 195 | |
| Blood loss NOS | NOS: not otherwise specified | 212 | 0% | 17 |
| Bloodshot eye | 228 | 0% | 16 | |
| Bloody diarrhoea | diarrhea with blood | 14,286 | 1.1% | 627 |
| Bone and joint disorder NOS | NOS: not otherwise specified | 1,377 | 0.1% | 290 |
| Bottles, Damaged | a product quality report, not a sign in an animal | 582 | 0% | 16 |
| Bradycardia | slow heart rate | 3,764 | 0.3% | 215 |
| Bradypnoea | 542 | 0% | 10 | |
| Brain disorder NOS | NOS: not otherwise specified | 233 | 0% | 18 |
| Breathing difficulty | 2,705 | 0.2% | 209 | |
| Bronchitis | 291 | 0% | 23 | |
| Bruising | 1,539 | 0.1% | 128 | |
| Bumping into walls | 519 | 0% | 96 | |
| Bumps on skin | 224 | 0% | 99 | |
| Cachexia | 206 | 0% | 9 | |
| Calculi | 377 | 0% | 12 | |
| Caps, Abnormal | a product quality report, not a sign in an animal | 3,840 | 0.3% | 69 |
| Cardiac arrest | 3,777 | 0.3% | 109 | |
| Cardiac disorder NOS | heart problem, type not specified | 11,767 | 0.9% | 100 |
| Cardiac enlargement | 1,489 | 0.1% | 86 | |
| Cardiomyopathy | 292 | 0% | 30 | |
| Cardiorespiratory arrest | 255 | 0% | 31 | |
| Cataract | 758 | 0.1% | 36 | |
| Cellulitis | 492 | 0% | 50 | |
| Central nervous system disorder NOS | NOS: not otherwise specified | 447 | 0% | 9 |
| Chattering of teeth | 386 | 0% | 45 | |
| Chewing - oral cavity disorder | 221 | 0% | 3 | |
| Chewing - pruritus | 756 | 0.1% | 97 | |
| Chronic renal failure | 249 | 0% | 11 | |
| Circling - behavioural disorder | 333 | 0% | 43 | |
| Circling - neurological disorder | 2,720 | 0.2% | 151 | |
| Circulatory collapse | 641 | 0.1% | 60 | |
| Circumstance or info capable of leading to medication error | 224 | 0% | 9 | |
| Claw / hoof / nail disorder NOS | NOS: not otherwise specified | 467 | 0% | 27 |
| Closed eyelid | 356 | 0% | 26 | |
| Closure, Abnormal | a product quality report, not a sign in an animal | 3,436 | 0.3% | 293 |
| Closure, Missing | a product quality report, not a sign in an animal | 876 | 0.1% | 107 |
| Cloudy eye (for Miosis, Mydriasis, Anisocoria, Nystagmus | 312 | 0% | 35 | |
| Coagulopathy | 1,303 | 0.1% | 18 | |
| Cognitive disorder NOS | NOS: not otherwise specified | 283 | 0% | 58 |
| Colic | 770 | 0.1% | 52 | |
| Colitis | 795 | 0.1% | 47 | |
| Collapse | 5,865 | 0.4% | 117 | |
| Collapse NOS | NOS: not otherwise specified | 3,607 | 0.3% | 308 |
| Collapse of leg | 523 | 0% | 73 | |
| Color, Abnormal | a product quality report, not a sign in an animal | 10,755 | 0.8% | 344 |
| Coma | 358 | 0% | 19 | |
| Confused | 417 | 0% | 1 | |
| Confusion | 4,582 | 0.3% | 223 | |
| Congested mucous membrane | 255 | 0% | 31 | |
| Congestion of mucous membrane | 223 | 0% | 4 | |
| Congestive heart failure | 437 | 0% | 59 | |
| Conjunctivitis | 1,304 | 0.1% | 48 | |
| Constipation | 2,573 | 0.2% | 160 | |
| Constricted pupils | 255 | 0% | 17 | |
| Containers, Abnormal | a product quality report, not a sign in an animal | 3,744 | 0.3% | 94 |
| Containers, Damaged | a product quality report, not a sign in an animal | 14,472 | 1.1% | 1,025 |
| Containers, Leaking | a product quality report, not a sign in an animal | 7,288 | 0.5% | 670 |
| Contamination NOS | NOS: not otherwise specified | 873 | 0.1% | 36 |
| Contamination, Foreign Object | 1,520 | 0.1% | 398 | |
| Contamination, Mold | 246 | 0% | 8 | |
| Contamination, Particulate Matter | 736 | 0.1% | 42 | |
| Convulsion | seizure | 12,721 | 0.9% | 72 |
| Coprophagia | 207 | 0% | 15 | |
| Corneal disorder NOS | NOS: not otherwise specified | 469 | 0% | 33 |
| Corneal oedema | 254 | 0% | 10 | |
| Corneal ulcer | 1,330 | 0.1% | 80 | |
| Cough | 8,798 | 0.7% | 431 | |
| Crackles on auscultation | 335 | 0% | 38 | |
| Crust | 2,082 | 0.2% | 169 | |
| Crying | 1,750 | 0.1% | 167 | |
| Crystalluria | 1,083 | 0.1% | 68 | |
| Culture/titer data abnormal | 1,527 | 0.1% | 6 | |
| Cushings disease NOS | NOS: not otherwise specified | 314 | 0% | 31 |
| Cyanosis | bluish gums or skin from low oxygen | 2,295 | 0.2% | 82 |
| Cystitis | 533 | 0% | 34 | |
| Deafness | 6,661 | 0.5% | 343 | |
| Deafness NOS | NOS: not otherwise specified | 325 | 0% | 16 |
| Death | 50,955 | 3.8% | 2,129 | |
| Death by euthanasia | the animal was euthanized | 29,798 | 2.2% | 2,056 |
| Death-slaughtered | 227 | 0% | 0 | |
| Death-treatment failure | 744 | 0.1% | 0 | |
| Decreased activity | 1,857 | 0.1% | 162 | |
| Decreased appetite | 17,847 | 1.3% | 1,580 | |
| Decreased body temperature | 768 | 0.1% | 74 | |
| Decreased bowel movements | 827 | 0.1% | 63 | |
| Decreased cholesterol (total) | 522 | 0% | 40 | |
| Decreased drinking | 1,250 | 0.1% | 168 | |
| Decreased haematocrit | 1,043 | 0.1% | 447 | |
| Decreased haemoglobin | 1,010 | 0.1% | 203 | |
| Decreased heart rate | 426 | 0% | 57 | |
| Decreased packed cell volume (PCV) | lower share of red cells in the blood | 1,813 | 0.1% | 116 |
| Decreased percentage of reticulocytes | 461 | 0% | 127 | |
| Decreased red blood cell count | 1,393 | 0.1% | 224 | |
| Decreased urine concentration | dilute urine | 4,725 | 0.4% | 191 |
| Defect Unknown/Not Specified | a product quality report, not a sign in an animal | 1,677 | 0.1% | 173 |
| Dehydration | 10,231 | 0.8% | 683 | |
| Delayed healing | 210 | 0% | 17 | |
| Demodicosis | 230 | 0% | 3 | |
| Dental calculus | 427 | 0% | 36 | |
| Dental disease | 580 | 0% | 60 | |
| Dependent oedema | 371 | 0% | 5 | |
| Depression | dull, quiet or withdrawn | 42,388 | 3.1% | 159 |
| Dermal cyst(s) | 436 | 0% | 29 | |
| Dermal mass | 1,460 | 0.1% | 78 | |
| Dermal thickening | 306 | 0% | 34 | |
| Dermatitis | inflamed skin | 4,529 | 0.3% | 176 |
| Dermatosis NOS | NOS: not otherwise specified | 342 | 0% | 9 |
| Device breakage/fracture | 503 | 0% | 60 | |
| Device Defective NOS | a product quality report, not a sign in an animal | 2,731 | 0.2% | 300 |
| Diabetes | 894 | 0.1% | 65 | |
| Diabetes mellitus | 1,189 | 0.1% | 39 | |
| Diabetic ketoacidosis | 630 | 0.1% | 130 | |
| Diabetic ketonuria | 395 | 0% | 4 | |
| Diarrhoea | diarrhea | 82,046 | 6.1% | 4,563 |
| Difficulty going up/down stairs | 290 | 0% | 98 | |
| Difficulty of Use | a product quality report, not a sign in an animal | 3,260 | 0.2% | 0 |
| Difficulty standing | 645 | 0.1% | 202 | |
| Difficulty to rise | 666 | 0.1% | 142 | |
| Digestive tract disorder NOS | digestive problem, type not specified | 21,171 | 1.6% | 150 |
| Digestive tract haemorrhage NOS | NOS: not otherwise specified | 350 | 0% | 8 |
| Digestive tract hypomotility | 268 | 0% | 11 | |
| Dilated pupils | 3,467 | 0.3% | 339 | |
| Discoloured urine | 1,535 | 0.1% | 65 | |
| Discomfort NOS | NOS: not otherwise specified | 1,131 | 0.1% | 176 |
| Disorder of gastrointestinal flora | 201 | 0% | 13 | |
| Disorder of red blood cell NOS | NOS: not otherwise specified | 382 | 0% | 36 |
| Disorientation | 5,533 | 0.4% | 409 | |
| Disoriented state | 672 | 0.1% | 66 | |
| Dispenser, Abnormal | a product quality report, not a sign in an animal | 3,091 | 0.2% | 9 |
| Disseminated intravascular coagulation | 407 | 0% | 7 | |
| Distension of abdomen | 2,573 | 0.2% | 130 | |
| Distress | 824 | 0.1% | 113 | |
| Drinking a lot | 2,092 | 0.2% | 112 | |
| Drooling | 7,943 | 0.6% | 724 | |
| Drooping eyelid | 401 | 0% | 32 | |
| Drug administered at inappropriate site | 1,240 | 0.1% | 182 | |
| Drug administration duration too long | 941 | 0.1% | 34 | |
| Drug administration error | 4,799 | 0.4% | 0 | |
| Drug dispensing error | 289 | 0% | 2 | |
| Drug dose administration interval too long | 3,323 | 0.2% | 136 | |
| Drug dose administration interval too short | 2,901 | 0.2% | 215 | |
| Drug dose omission | a scheduled administration was missed | 3,957 | 0.3% | 233 |
| Drug dose prescribing error | 213 | 0% | 4 | |
| Drug label confusion | 254 | 0% | 25 | |
| Drug prescribing error | 209 | 0% | 0 | |
| Drug schedule prescribing error | 238 | 0% | 0 | |
| Drunken gait | 557 | 0% | 53 | |
| Dry eye | 352 | 0% | 23 | |
| Dry mouth | 289 | 0% | 9 | |
| Dry mucous membrane | 1,224 | 0.1% | 135 | |
| Dry nose | 314 | 0% | 21 | |
| Dry skin | 1,252 | 0.1% | 54 | |
| Dull | 652 | 0.1% | 118 | |
| Dullness | 744 | 0.1% | 62 | |
| Duodenal ulcer | 208 | 0% | 6 | |
| Dysphagia | 401 | 0% | 8 | |
| Dysphoria | 693 | 0.1% | 115 | |
| Dyspnoea | difficulty breathing | 7,607 | 0.6% | 136 |
| Dysuria | 236 | 0% | 6 | |
| Ear canal erythema | 328 | 0% | 40 | |
| Ear canal inflammation | 271 | 0% | 47 | |
| Ear discharge | 1,171 | 0.1% | 100 | |
| Ear infection NOS | NOS: not otherwise specified | 2,186 | 0.2% | 230 |
| Ear irritation | 212 | 0% | 16 | |
| Ear pain | 469 | 0% | 48 | |
| Ear pruritus | 364 | 0% | 36 | |
| Ear twitching | 214 | 0% | 16 | |
| Ecchymosis | 1,118 | 0.1% | 21 | |
| Electrolyte disorder | 1,169 | 0.1% | 66 | |
| Elevated alanine aminotransferase (ALT) | a liver enzyme above the normal range | 26,969 | 2% | 1,318 |
| Elevated amylase | a pancreatic enzyme above the normal range | 3,593 | 0.3% | 174 |
| Elevated aspartate aminotransferase (AST) | a liver and muscle enzyme above the normal range | 5,339 | 0.4% | 204 |
| Elevated bile acids | 1,316 | 0.1% | 41 | |
| Elevated blood urea nitrogen (BUN) | a kidney value above the normal range | 17,526 | 1.3% | 791 |
| Elevated cholesterol (total) | 3,181 | 0.2% | 333 | |
| Elevated creatine-kinase (CK) | a muscle enzyme above the normal range | 1,676 | 0.1% | 96 |
| Elevated creatinine | a kidney value above the normal range | 13,553 | 1% | 564 |
| Elevated gamma-glutamyl transferase (GGT) | a liver enzyme above the normal range | 4,222 | 0.3% | 262 |
| Elevated globulins | 2,948 | 0.2% | 372 | |
| Elevated haematocrit | 311 | 0% | 129 | |
| Elevated lipase | a pancreatic enzyme above the normal range | 2,936 | 0.2% | 168 |
| Elevated liver enzymes | liver enzymes above the normal range | 8,231 | 0.6% | 0 |
| Elevated liver enzymes NOS | NOS: not otherwise specified | 894 | 0.1% | 347 |
| Elevated pancreatic enzymes | 412 | 0% | 46 | |
| Elevated protein:creatinine ratio | 395 | 0% | 74 | |
| Elevated renal parameters | kidney values above the normal range | 2,373 | 0.2% | 165 |
| Elevated serum alkaline phosphatase (ALP) | a liver and bone enzyme above the normal range | 2,737 | 0.2% | 1,168 |
| Elevated serum alkaline phosphatase (SAP) | a liver and bone enzyme above the normal range | 22,104 | 1.6% | 0 |
| Elevated symmetrical dimethylarginine (SDMA) | a kidney value above the normal range | 1,963 | 0.1% | 436 |
| Elevated temperature | 2,438 | 0.2% | 212 | |
| Elevated thyroxine (T4) | 230 | 0% | 43 | |
| Elevated total bilirubin | bilirubin above the normal range | 10,274 | 0.8% | 463 |
| Elevated triglyceride | 983 | 0.1% | 121 | |
| Embolism | 209 | 0% | 1 | |
| Emesis | vomiting | 69,445 | 5.1% | 292 |
| Emesis (multiple) | vomiting more than once | 19,169 | 1.4% | 1,950 |
| Enlarged liver | 616 | 0.1% | 62 | |
| Enlarged lymph node (localised) | 592 | 0% | 97 | |
| Enlarged lymph nodes (generalised) | 344 | 0% | 32 | |
| Enteritis | 565 | 0% | 22 | |
| Eosinopenia | 722 | 0.1% | 315 | |
| Eosinopenia | 366 | 0% | 0 | |
| Eosinophilia | 1,540 | 0.1% | 127 | |
| Epilepsy | 217 | 0% | 17 | |
| Epileptic seizure | 217 | 0% | 5 | |
| Epiphora | 475 | 0% | 32 | |
| Epistaxis | nosebleed | 1,706 | 0.1% | 47 |
| Eruption | 381 | 0% | 3 | |
| Erythema (for urticaria see Immune SOC) | 4,726 | 0.4% | 150 | |
| Erythematous rash | 432 | 0% | 19 | |
| Excessive appetite | 223 | 0% | 23 | |
| Excessive chewing, licking and/or grooming | 713 | 0.1% | 167 | |
| Excessive licking and/or grooming | 2,069 | 0.2% | 0 | |
| Excessive thirst | 1,147 | 0.1% | 112 | |
| Excitation | 379 | 0% | 28 | |
| Excoriation | 545 | 0% | 60 | |
| Exercise intolerance | 399 | 0% | 13 | |
| Expired drug administered | 700 | 0.1% | 44 | |
| External ear disorder NOS | NOS: not otherwise specified | 591 | 0% | 11 |
| Eye disorder NOS (for photophobia see 'neurological') | 2,593 | 0.2% | 0 | |
| Eye disorder NOS (for Photophobia see neurological) | 478 | 0% | 155 | |
| Eye haemorrhage | 228 | 0% | 5 | |
| Eye irritation | 1,628 | 0.1% | 55 | |
| Eye itching | 201 | 0% | 12 | |
| Eye pain | 637 | 0.1% | 18 | |
| Eye redness | 1,382 | 0.1% | 61 | |
| Eyelid oedema | 1,084 | 0.1% | 14 | |
| Eyes rolling back | 785 | 0.1% | 43 | |
| Face and neck swelling | 244 | 0% | 16 | |
| Facial oedema | swollen face | 4,693 | 0.4% | 12 |
| Facial paralysis | 697 | 0.1% | 61 | |
| Facial pruritus | 362 | 0% | 85 | |
| Facial swelling | 8,582 | 0.6% | 721 | |
| Faecal incontinence | 1,412 | 0.1% | 138 | |
| Falling | 4,574 | 0.3% | 549 | |
| Fasciculation | 398 | 0% | 22 | |
| Fatigue | 219 | 0% | 25 | |
| Febrile | 1,167 | 0.1% | 64 | |
| Feeling depressed | 321 | 0% | 0 | |
| Female reproductive tract disorder NOS | NOS: not otherwise specified | 233 | 0% | 5 |
| Fever | 17,756 | 1.3% | 838 | |
| Fixed pupil | 619 | 0.1% | 16 | |
| Flaking skin | 1,102 | 0.1% | 70 | |
| Flatulence | gas | 1,594 | 0.1% | 69 |
| Fluid in abdomen NOS | NOS: not otherwise specified | 727 | 0.1% | 68 |
| Fly biting behaviour | 550 | 0% | 53 | |
| Foam in the mouth | 289 | 0% | 34 | |
| Foaming at the mouth | 3,616 | 0.3% | 325 | |
| Focal seizure | 404 | 0% | 98 | |
| Food allergy | 211 | 0% | 10 | |
| Food refusal | 432 | 0% | 92 | |
| Found dead | 612 | 0.1% | 73 | |
| Fracture | 298 | 0% | 52 | |
| Frequent urination | 1,578 | 0.1% | 159 | |
| Fungal skin infection NOS | NOS: not otherwise specified | 479 | 0% | 25 |
| Gagging | 2,586 | 0.2% | 143 | |
| Gait abnormality | 1,520 | 0.1% | 220 | |
| Gall bladder & bile duct disorder NOS | NOS: not otherwise specified | 1,043 | 0.1% | 83 |
| Gastric bloat | 348 | 0% | 10 | |
| Gastric perforation | 814 | 0.1% | 17 | |
| Gastric ulcer | 904 | 0.1% | 32 | |
| Gastric ulceration NOS | NOS: not otherwise specified | 254 | 0% | 11 |
| Gastric volvulus | 237 | 0% | 3 | |
| Gastritis | 606 | 0% | 27 | |
| Gastroenteritis | 1,183 | 0.1% | 74 | |
| Gastrointestinal foreign body NOS | NOS: not otherwise specified | 282 | 0% | 38 |
| Gel/Paste, Abnormal | 213 | 0% | 3 | |
| General hair loss | 1,034 | 0.1% | 40 | |
| General illness | 2,112 | 0.2% | 323 | |
| General pain | 773 | 0.1% | 35 | |
| Generalised itching | 1,555 | 0.1% | 128 | |
| Generalised rash | 387 | 0% | 13 | |
| Generalised weakness | 730 | 0.1% | 51 | |
| Genital tract licking | 216 | 0% | 30 | |
| Gingival disorder | 339 | 0% | 7 | |
| Gingival hyperplasia | 701 | 0.1% | 18 | |
| Gingivitis | 444 | 0% | 36 | |
| Glaucoma | 279 | 0% | 16 | |
| Glazed eye | 1,571 | 0.1% | 60 | |
| Glucosuria | sugar in the urine | 1,948 | 0.1% | 228 |
| Grand mal seizure | 944 | 0.1% | 151 | |
| Granules/Powder, Abnormal | 730 | 0.1% | 3 | |
| Granuloma | 223 | 0% | 12 | |
| Grooming disorder | 240 | 0% | 44 | |
| Growling | 284 | 0% | 71 | |
| Gum disorder NOS | NOS: not otherwise specified | 206 | 0% | 13 |
| Gut sounds increased | 533 | 0% | 22 | |
| Haemangiosarcoma | 215 | 0% | 22 | |
| Haematemesis | 796 | 0.1% | 46 | |
| Haematochezia | fresh blood in the stool | 2,342 | 0.2% | 72 |
| Haematuria | blood in the urine | 5,038 | 0.4% | 281 |
| Haemoconcentration | 290 | 0% | 14 | |
| Haemolytic anaemia | 291 | 0% | 4 | |
| Haemoptysis | 558 | 0% | 1 | |
| Haemorrhage NOS | NOS: not otherwise specified | 1,497 | 0.1% | 79 |
| Haemorrhagic diarrhoea | 684 | 0.1% | 45 | |
| Haemorrhagic gastroenteritis | 473 | 0% | 41 | |
| Hair change | 600 | 0% | 43 | |
| Hair coat discolouration | 788 | 0.1% | 29 | |
| Hair loss NOS | NOS: not otherwise specified | 3,232 | 0.2% | 300 |
| Hair modification NOS | NOS: not otherwise specified | 821 | 0.1% | 10 |
| Hair shedding | 1,155 | 0.1% | 35 | |
| Halitosis | 657 | 0.1% | 20 | |
| Hallucination | 521 | 0% | 31 | |
| Hard, clumping | a product quality report, not a sign in an animal | 2,964 | 0.2% | 79 |
| Head bobbing | 1,766 | 0.1% | 139 | |
| Head down | 571 | 0% | 83 | |
| Head pressing | 516 | 0% | 35 | |
| Head shake - behavioural disorder | 1,155 | 0.1% | 107 | |
| Head shake - ear disorder | 1,517 | 0.1% | 154 | |
| Head tilt - ear disorder | 2,759 | 0.2% | 121 | |
| Head tilt - neurological disorder | 1,775 | 0.1% | 312 | |
| Head tremor | 2,489 | 0.2% | 213 | |
| Headache | 682 | 0.1% | 22 | |
| Hearing affected | 254 | 0% | 11 | |
| Hearing decreased | 396 | 0% | 29 | |
| Heart failure | 741 | 0.1% | 35 | |
| Heart murmur | 2,338 | 0.2% | 288 | |
| Heart valve disorder | 205 | 0% | 19 | |
| Heavy breathing | 863 | 0.1% | 202 | |
| Hematocrit(hct) high, blood | 249 | 0% | 0 | |
| Hepatic disorder NOS | NOS: not otherwise specified | 329 | 0% | 15 |
| Hepatic neoplasm | 433 | 0% | 8 | |
| Hepatitis | 773 | 0.1% | 24 | |
| Hepatomegaly | 1,494 | 0.1% | 98 | |
| Hepatopathy | liver disorder | 1,583 | 0.1% | 61 |
| Hiding | 5,729 | 0.4% | 511 | |
| High blood pressure | 601 | 0% | 87 | |
| High pancreatic-specific lipase | 934 | 0.1% | 237 | |
| High sodium-potassium ratio (Na:K ratio) | 532 | 0% | 80 | |
| Hind limb ataxia | uncoordinated hind legs | 2,012 | 0.2% | 218 |
| Hind limb paralysis | paralysed hind legs | 1,628 | 0.1% | 132 |
| Hind limb paresis | weak hind legs | 3,771 | 0.3% | 247 |
| Histiocytoma | 263 | 0% | 17 | |
| Hives | 8,339 | 0.6% | 652 | |
| Horizontal nystagmus | 727 | 0.1% | 89 | |
| Horner's syndrome | 689 | 0.1% | 42 | |
| Hot spot (pyotraumatic dermatitis) | moist, inflamed patch of skin | 1,608 | 0.1% | 112 |
| Hyperactivity | 10,836 | 0.8% | 477 | |
| Hyperadrenocorticism | 310 | 0% | 7 | |
| Hyperaemic mucous membrane | 347 | 0% | 21 | |
| Hyperaesthesia | over-sensitive to touch | 1,587 | 0.1% | 78 |
| Hyperalbuminaemia | 1,190 | 0.1% | 143 | |
| Hypercalcaemia | high blood calcium | 2,047 | 0.2% | 211 |
| Hyperchloraemia | 559 | 0% | 48 | |
| Hyperexcitation | 955 | 0.1% | 13 | |
| Hyperextension | 549 | 0% | 20 | |
| Hyperglycaemia | high blood sugar | 7,863 | 0.6% | 720 |
| Hyperhidrosis | 428 | 0% | 0 | |
| Hyperkalaemia | high blood potassium | 4,007 | 0.3% | 203 |
| Hyperkeratosis | 243 | 0% | 15 | |
| Hypermetria | 205 | 0% | 27 | |
| Hypernatremia | 1,141 | 0.1% | 109 | |
| Hyperphosphataemia | high blood phosphate | 7,003 | 0.5% | 388 |
| Hyperpigmentation | 846 | 0.1% | 41 | |
| Hyperproteinaemia | high blood protein | 2,275 | 0.2% | 223 |
| Hypersalivation | drooling | 15,871 | 1.2% | 502 |
| Hypersensitivity NOS | NOS: not otherwise specified | 353 | 0% | 39 |
| Hypersensitivity reaction | 1,230 | 0.1% | 497 | |
| Hypertension | high blood pressure | 1,685 | 0.1% | 153 |
| Hyperthermia | raised body temperature | 1,566 | 0.1% | 135 |
| Hyperthyroidism | 357 | 0% | 32 | |
| Hyperventilation | 260 | 0% | 20 | |
| Hyphaemia | 234 | 0% | 14 | |
| Hypoadrenocorticism | 865 | 0.1% | 5 | |
| Hypoaesthesia | 366 | 0% | 2 | |
| Hypoalbuminaemia | low blood albumin | 6,055 | 0.5% | 286 |
| Hypocalcaemia | 483 | 0% | 134 | |
| Hypocalcaemic condition | 1,018 | 0.1% | 3 | |
| Hypochloraemia | low blood chloride | 2,186 | 0.2% | 325 |
| Hypocortisolaemia | 521 | 0% | 94 | |
| Hypoglycaemia | low blood sugar | 5,240 | 0.4% | 415 |
| Hypokalaemia | low blood potassium | 1,995 | 0.2% | 453 |
| Hyponatremia | low blood sodium | 2,364 | 0.2% | 201 |
| Hypophosphataemia | 930 | 0.1% | 123 | |
| Hypoproteinaemia | low blood protein | 3,610 | 0.3% | 151 |
| Hyposthenuria | 524 | 0% | 99 | |
| Hypotension | low blood pressure | 2,024 | 0.2% | 215 |
| Hypothermia | low body temperature | 4,124 | 0.3% | 188 |
| Hypothyroidism | underactive thyroid | 1,753 | 0.1% | 79 |
| Icterus | jaundice (yellowing) | 5,388 | 0.4% | 111 |
| Ileus | 213 | 0% | 33 | |
| Immediate pain upon injection | 586 | 0% | 71 | |
| Immune mediated haemolytic anaemia | the immune system destroying red blood cells | 2,252 | 0.2% | 121 |
| Immune mediated thrombocytopenia | 753 | 0.1% | 86 | |
| Impaired consciousness | 559 | 0% | 34 | |
| Impaired hearing | 322 | 0% | 19 | |
| Impaired proprioception | 289 | 0% | 31 | |
| Impaired vision | 1,326 | 0.1% | 72 | |
| Impaired vocalisation | 280 | 0% | 20 | |
| Implant, Abnormal | 547 | 0% | 10 | |
| Inappetence | reduced appetite | 9,095 | 0.7% | 501 |
| Inappropriate defecation | 2,179 | 0.2% | 178 | |
| Inappropriate elimination NOS | NOS: not otherwise specified | 252 | 0% | 77 |
| Inappropriate preparation of medication | 578 | 0% | 4 | |
| Inappropriate schedule of drug administration | 1,119 | 0.1% | 64 | |
| Inappropriate urination | 5,701 | 0.4% | 542 | |
| Incoordination | 885 | 0.1% | 57 | |
| Incorrect dose administered NOS | NOS: not otherwise specified | 1,391 | 0.1% | 42 |
| Incorrect route of drug administration | 1,268 | 0.1% | 89 | |
| Incorrect storage of drug | 415 | 0% | 30 | |
| Increased appetite | 827 | 0.1% | 87 | |
| Increased borborygmus | 549 | 0% | 34 | |
| Increased bowel movements (frequency) | 306 | 0% | 28 | |
| Increased coagulation time | 265 | 0% | 22 | |
| Increased drinking | 379 | 0% | 205 | |
| Increased heart rate | 1,659 | 0.1% | 159 | |
| Increased mortality rate | 250 | 0% | 7 | |
| Increased packed cell volume (PCV) | 698 | 0.1% | 37 | |
| Increased percentage reticulocytes | 1,154 | 0.1% | 156 | |
| Increased red blood cell count | 400 | 0% | 74 | |
| Increased respiratory rate | 1,540 | 0.1% | 205 | |
| Increased salivation | 623 | 0.1% | 47 | |
| Increased seizure frequency | 306 | 0% | 45 | |
| Increased sensitivity to sound | 248 | 0% | 18 | |
| Increased sexual interest | 319 | 0% | 6 | |
| Increased skin sensitivity | 291 | 0% | 40 | |
| Increased sweating | 239 | 0% | 15 | |
| Increased urine concentration | 411 | 0% | 49 | |
| Increased weight | 356 | 0% | 26 | |
| Ineffective, analgesia | legacy FDA term: the product did not have the expected effect (analgesia) | 995 | 0.1% | 2 |
| Ineffective, anesthesia | legacy FDA term: the product did not have the expected effect (anesthesia) | 2,704 | 0.2% | 11 |
| Ineffective, antibiotic | legacy FDA term: the product did not have the expected effect (antibiotic) | 596 | 0% | 0 |
| Ineffective, antiemetic | legacy FDA term: the product did not have the expected effect (antiemetic) | 728 | 0.1% | 4 |
| Ineffective, antiinflammatory | legacy FDA term: the product did not have the expected effect (antiinflammatory) | 1,812 | 0.1% | 7 |
| Ineffective, appetite suppression | legacy FDA term: the product did not have the expected effect (appetite suppression) | 430 | 0% | 0 |
| Ineffective, ascarids | legacy FDA term: the product did not have the expected effect (ascarids) | 290 | 0% | 0 |
| Ineffective, ascarids NOS | legacy FDA term: the product did not have the expected effect (ascarids nos) | 19,031 | 1.4% | 0 |
| Ineffective, atopy control | legacy FDA term: the product did not have the expected effect (atopy control) | 3,321 | 0.2% | 12 |
| Ineffective, coccidia | legacy FDA term: the product did not have the expected effect (coccidia) | 1,334 | 0.1% | 0 |
| Ineffective, cognitive dysfunc | legacy FDA term: the product did not have the expected effect (cognitive dysfunc) | 444 | 0% | 0 |
| Ineffective, cushings | legacy FDA term: the product did not have the expected effect (cushings) | 1,277 | 0.1% | 0 |
| Ineffective, delayed effect | legacy FDA term: the product did not have the expected effect (delayed effect) | 361 | 0% | 3 |
| Ineffective, estrus suppressio | legacy FDA term: the product did not have the expected effect (estrus suppressio) | 578 | 0% | 0 |
| Ineffective, estrus synchroniz | legacy FDA term: the product did not have the expected effect (estrus synchroniz) | 614 | 0.1% | 0 |
| Ineffective, euthanasia | legacy FDA term: the product did not have the expected effect (euthanasia) | 895 | 0.1% | 4 |
| Ineffective, gastric ulcer(s) | legacy FDA term: the product did not have the expected effect (gastric ulcer(s)) | 809 | 0.1% | 37 |
| Ineffective, glycemic control | legacy FDA term: the product did not have the expected effect (glycemic control) | 3,571 | 0.3% | 58 |
| Ineffective, heartworm adults | legacy FDA term: the product did not have the expected effect (heartworm adults) | 4,328 | 0.3% | 0 |
| Ineffective, heartworm larvae | legacy FDA term: the product did not have the expected effect (heartworm larvae) | 69,276 | 5.1% | 0 |
| Ineffective, heartworm microfi | legacy FDA term: the product did not have the expected effect (heartworm microfi) | 285 | 0% | 0 |
| Ineffective, hooks | legacy FDA term: the product did not have the expected effect (hooks) | 13,040 | 1% | 0 |
| Ineffective, lice biting | legacy FDA term: the product did not have the expected effect (lice biting) | 659 | 0.1% | 0 |
| Ineffective, loss of effect | legacy FDA term: the product did not have the expected effect (loss of effect) | 4,530 | 0.3% | 87 |
| Ineffective, other drug(s) | legacy FDA term: the product did not have the expected effect (other drug(s)) | 434 | 0% | 19 |
| Ineffective, parasite(s) NOS | legacy FDA term: the product did not have the expected effect (parasite(s) nos) | 789 | 0.1% | 7 |
| Ineffective, production (milk) | legacy FDA term: the product did not have the expected effect (production (milk)) | 375 | 0% | 0 |
| Ineffective, reversal | legacy FDA term: the product did not have the expected effect (reversal) | 480 | 0% | 2 |
| Ineffective, sedation | legacy FDA term: the product did not have the expected effect (sedation) | 2,601 | 0.2% | 36 |
| Ineffective, strongyles | legacy FDA term: the product did not have the expected effect (strongyles) | 627 | 0.1% | 2 |
| Ineffective, weight loss | legacy FDA term: the product did not have the expected effect (weight loss) | 336 | 0% | 0 |
| Ineffective, whips | legacy FDA term: the product did not have the expected effect (whips) | 2,008 | 0.2% | 0 |
| Ineffective, worms | legacy FDA term: the product did not have the expected effect (worms) | 465 | 0% | 0 |
| Ineffective, worms NOS | legacy FDA term: the product did not have the expected effect (worms nos) | 1,374 | 0.1% | 16 |
| Infectious disease NOS | NOS: not otherwise specified | 242 | 0% | 33 |
| Infertility NOS | NOS: not otherwise specified | 514 | 0% | 1 |
| Injected sclera | 250 | 0% | 27 | |
| Injection site abscess | abscess where the injection was given | 1,796 | 0.1% | 101 |
| Injection site alopecia | hair loss where the injection was given | 711 | 0.1% | 34 |
| Injection site bleeding | bleeding where the injection was given | 1,141 | 0.1% | 84 |
| Injection site bruising | bruising where the injection was given | 538 | 0% | 60 |
| Injection site complication NOS | complication nos where the injection was given | 301 | 0% | 37 |
| Injection site erythema | reddened skin where the injection was given | 410 | 0% | 44 |
| Injection site granuloma | granuloma where the injection was given | 207 | 0% | 23 |
| Injection site hair loss | hair loss where the injection was given | 317 | 0% | 37 |
| Injection site infection | infection where the injection was given | 407 | 0% | 24 |
| Injection site inflammation | inflammation where the injection was given | 1,514 | 0.1% | 83 |
| Injection site lesion | lesion where the injection was given | 521 | 0% | 41 |
| Injection site lump | lump where the injection was given | 2,254 | 0.2% | 204 |
| Injection site mass | mass where the injection was given | 920 | 0.1% | 0 |
| Injection site mass NOS | mass nos where the injection was given | 214 | 0% | 67 |
| Injection site mucopurulent discharge | mucopurulent discharge where the injection was given | 257 | 0% | 19 |
| Injection site necrosis | necrosis where the injection was given | 1,038 | 0.1% | 45 |
| Injection site oedema | oedema where the injection was given | 721 | 0.1% | 20 |
| Injection site pain | pain where the injection was given | 5,895 | 0.4% | 236 |
| Injection site pruritus | itching where the injection was given | 340 | 0% | 12 |
| Injection site reaction NOS | reaction nos where the injection was given | 1,180 | 0.1% | 74 |
| Injection site reddening | reddening where the injection was given | 347 | 0% | 55 |
| Injection site scab | scab where the injection was given | 408 | 0% | 47 |
| Injection site seroma | seroma where the injection was given | 419 | 0% | 11 |
| Injection site serosanguinous discharge | serosanguinous discharge where the injection was given | 283 | 0% | 25 |
| Injection site skin discolouration | skin discolouration where the injection was given | 256 | 0% | 53 |
| Injection site swelling | swelling where the injection was given | 8,411 | 0.6% | 435 |
| Injection site ulcer | ulcer where the injection was given | 292 | 0% | 27 |
| Injection site warmth | warmth where the injection was given | 265 | 0% | 30 |
| Injection site weeping | weeping where the injection was given | 235 | 0% | 21 |
| Intentional misuse | use that was knowingly different from the label | 4,445 | 0.3% | 2,556 |
| Intervertebral disc disease | 419 | 0% | 86 | |
| Intestinal disorder NOS | NOS: not otherwise specified | 881 | 0.1% | 109 |
| Intestinal perforation | 1,403 | 0.1% | 14 | |
| Involuntary defecation | 675 | 0.1% | 75 | |
| Irregular breathing | 401 | 0% | 13 | |
| Irritability | 360 | 0% | 58 | |
| Isosthenuria | 356 | 0% | 81 | |
| Itching | 10,747 | 0.8% | 766 | |
| Itchy ears | 219 | 0% | 32 | |
| Itchy skin | 1,006 | 0.1% | 69 | |
| Jaundice | 993 | 0.1% | 71 | |
| Jaw disorder | 372 | 0% | 22 | |
| Joint effusion | 352 | 0% | 48 | |
| Joint pain | 830 | 0.1% | 91 | |
| Joint swelling | 1,054 | 0.1% | 170 | |
| Keratoconjunctivitis sicca | 943 | 0.1% | 26 | |
| Ketonuria | 719 | 0.1% | 230 | |
| Ketosis | ketones building up in the body | 3,146 | 0.2% | 992 |
| Knuckling | 923 | 0.1% | 211 | |
| Labeled drug-species interaction | 312 | 0% | 14 | |
| Labelled drug-drug interaction medication error | 3,362 | 0.3% | 1 | |
| Labels, Abnormal | a product quality report, not a sign in an animal | 212 | 0% | 16 |
| Laboured breathing | 2,624 | 0.2% | 195 | |
| Lack of coordination | 235 | 0% | 32 | |
| Lack of efficacy - NOS | the product did not have the expected effect | 56,123 | 4.1% | 4,084 |
| Lack of efficacy (bacteria) - Anaplasma | the product did not have the expected effect: Anaplasma bacteria | 3,860 | 0.3% | 1,851 |
| Lack of efficacy (bacteria) - Borrelia | the product did not have the expected effect: Borrelia (Lyme disease bacteria) | 12,009 | 0.9% | 2,816 |
| Lack of efficacy (bacteria) - Ehrlichia | the product did not have the expected effect: Ehrlichia bacteria | 2,922 | 0.2% | 759 |
| Lack of efficacy (bacteria) - NOS | the product did not have the expected effect: target not specified | 11,076 | 0.8% | 221 |
| Lack of efficacy (ectoparasite) - Demodex | the product did not have the expected effect: Demodex | 330 | 0% | 20 |
| Lack of efficacy (ectoparasite) - ear mite | the product did not have the expected effect: ear mites | 1,714 | 0.1% | 48 |
| Lack of efficacy (ectoparasite) - flea | the product did not have the expected effect: fleas | 63,352 | 4.7% | 6,043 |
| Lack of efficacy (ectoparasite) - lice | the product did not have the expected effect: lice | 2,376 | 0.2% | 23 |
| Lack of efficacy (ectoparasite) - mite NOS | the product did not have the expected effect: mite NOS | 616 | 0.1% | 14 |
| Lack of efficacy (ectoparasite) - NOS | the product did not have the expected effect: target not specified | 2,282 | 0.2% | 47 |
| Lack of efficacy (ectoparasite) - Sarcoptes | the product did not have the expected effect: Sarcoptes | 486 | 0% | 15 |
| Lack of efficacy (ectoparasite) - tick NOS | the product did not have the expected effect: ticks | 17,092 | 1.3% | 1,797 |
| Lack of efficacy (endoparasite) - heartworm | the product did not have the expected effect: heartworm | 52,940 | 3.9% | 5,628 |
| Lack of efficacy (endoparasite) - hookworm | the product did not have the expected effect: hookworms | 49,844 | 3.7% | 4,482 |
| Lack of efficacy (endoparasite) - NOS | the product did not have the expected effect: target not specified | 3,365 | 0.3% | 172 |
| Lack of efficacy (endoparasite) - roundworm NOS | the product did not have the expected effect: roundworms | 13,976 | 1% | 2,030 |
| Lack of efficacy (endoparasite) - tapeworm | the product did not have the expected effect: tapeworms | 8,900 | 0.7% | 1,354 |
| Lack of efficacy (endoparasite) - whipworm | the product did not have the expected effect: whipworms | 8,930 | 0.7% | 552 |
| Lack of efficacy (flea) | the product did not have the expected effect: fleas | 8,324 | 0.6% | 0 |
| Lack of efficacy (fungi) - NOS | the product did not have the expected effect: target not specified | 293 | 0% | 136 |
| Lack of efficacy (heartworm) | the product did not have the expected effect: heartworm | 1,001 | 0.1% | 0 |
| Lack of efficacy (lice) | the product did not have the expected effect: lice | 450 | 0% | 0 |
| Lack of efficacy (protozoa) | the product did not have the expected effect: protozoa | 291 | 0% | 0 |
| Lack of efficacy (protozoa) - Coccidia | the product did not have the expected effect: coccidia | 4,943 | 0.4% | 185 |
| Lack of efficacy (protozoa) - Ehrlichia | the product did not have the expected effect: Ehrlichia bacteria | 251 | 0% | 0 |
| Lack of efficacy (protozoa) - Giardia | the product did not have the expected effect: Giardia | 606 | 0% | 134 |
| Lack of efficacy (protozoa) - NOS | the product did not have the expected effect: target not specified | 738 | 0.1% | 14 |
| Lack of efficacy (roundworm) | the product did not have the expected effect: roundworms | 2,765 | 0.2% | 0 |
| Lack of efficacy (tapeworm) | the product did not have the expected effect: tapeworms | 990 | 0.1% | 0 |
| Lack of efficacy (tick) | the product did not have the expected effect: ticks | 6,102 | 0.5% | 0 |
| Lack of efficacy (virus) - parvovirus (including feline panleukopenia) | the product did not have the expected effect: parvovirus (including feline panleukopenia) | 310 | 0% | 62 |
| Lack of response to owner | 455 | 0% | 57 | |
| Lameness | 5,579 | 0.4% | 405 | |
| Laminitis | 312 | 0% | 5 | |
| Lateral recumbency | lying on the side, unable to rise | 3,460 | 0.3% | 353 |
| Lethargy | unusually tired or inactive | 93,420 | 6.9% | 5,754 |
| Leucocytosis NOS | high white blood cell count | 11,935 | 0.9% | 436 |
| Leucopenia NOS | low white blood cell count | 4,117 | 0.3% | 278 |
| Leukocytosis NOS | NOS: not otherwise specified | 204 | 0% | 200 |
| Licking | 2,509 | 0.2% | 261 | |
| Licking at application site | 1,049 | 0.1% | 72 | |
| Licking at injection site | 261 | 0% | 37 | |
| Limb non-weight bearing | 508 | 0% | 139 | |
| Limb weakness | 3,681 | 0.3% | 527 | |
| Limping | 2,550 | 0.2% | 315 | |
| Limpness | 487 | 0% | 66 | |
| Lip licking | 928 | 0.1% | 58 | |
| Lip oedema | 1,167 | 0.1% | 1 | |
| Lip smacking | 356 | 0% | 44 | |
| Lipaemia | 382 | 0% | 41 | |
| Lipoma | 365 | 0% | 36 | |
| Listless | 1,314 | 0.1% | 76 | |
| Liver disorder NOS | NOS: not otherwise specified | 1,351 | 0.1% | 67 |
| Liver failure | 983 | 0.1% | 35 | |
| Liver tumour | 317 | 0% | 26 | |
| Local erythema | 233 | 0% | 173 | |
| Local swelling (not application site) | 1,325 | 0.1% | 186 | |
| Localised hair loss | 1,713 | 0.1% | 189 | |
| Localised itching | 718 | 0.1% | 61 | |
| Localised oedema (not application site) | 545 | 0% | 50 | |
| Localised pain NOS | NOS: not otherwise specified | 1,975 | 0.2% | 162 |
| Localised rash | 580 | 0% | 47 | |
| Locking Mechanism Abnormal | 823 | 0.1% | 10 | |
| Locomotor disturbance | 838 | 0.1% | 2 | |
| Loose stool | 10,354 | 0.8% | 405 | |
| Loss of bowel control | 449 | 0% | 55 | |
| Loss of condition | 627 | 0.1% | 14 | |
| Loss of consciousness | 1,411 | 0.1% | 31 | |
| Loss of hearing | 1,707 | 0.1% | 249 | |
| Loss of vision | 409 | 0% | 45 | |
| Loss of voluntary movement | 202 | 0% | 27 | |
| Lot # and /or Expiration date missing | 535 | 0% | 26 | |
| Lot # and/or Expiration date illegible | 368 | 0% | 14 | |
| Low blood pressure | 627 | 0.1% | 90 | |
| Low blood urea nitrogen (BUN) | 955 | 0.1% | 80 | |
| Low creatinine | 527 | 0% | 111 | |
| Low platelet count | 2,283 | 0.2% | 350 | |
| Low sodium-potassium ratio (Na:K ratio) | 1,195 | 0.1% | 106 | |
| Low thyroxine (T4) | 656 | 0.1% | 124 | |
| Lumbar pain | 397 | 0% | 44 | |
| Lung oedema | 1,230 | 0.1% | 16 | |
| Lung sound | 245 | 0% | 8 | |
| Lying down | 907 | 0.1% | 245 | |
| Lymphadenopathy | enlarged lymph nodes | 1,629 | 0.1% | 81 |
| Lymphocytosis | 1,356 | 0.1% | 146 | |
| Lymphoma | 1,125 | 0.1% | 91 | |
| Lymphopenia | low lymphocyte count | 3,241 | 0.2% | 408 |
| Malaise | generally unwell | 4,968 | 0.4% | 218 |
| Malodour | 1,295 | 0.1% | 67 | |
| Mammary gland disorder NOS | NOS: not otherwise specified | 348 | 0% | 11 |
| Mammary gland oedema | 426 | 0% | 4 | |
| Mass NOS | NOS: not otherwise specified | 566 | 0% | 197 |
| Mast cell tumour | 392 | 0% | 83 | |
| Mastitis NOS | NOS: not otherwise specified | 801 | 0.1% | 12 |
| Medication error | 1,235 | 0.1% | 0 | |
| Medication error NOS | a mistake in giving the product, type not specified | 5,118 | 0.4% | 3,252 |
| Megaoesophagus | 203 | 0% | 9 | |
| Melaena | dark, tarry stool containing digested blood | 3,734 | 0.3% | 38 |
| Mental confusion | 257 | 0% | 18 | |
| Mental impairment NOS | NOS: not otherwise specified | 725 | 0.1% | 61 |
| Metastatic neoplasia | 297 | 0% | 32 | |
| Microorganisms, urine | 746 | 0.1% | 3 | |
| Milk production decrease | 697 | 0.1% | 14 | |
| Miosis | 595 | 0% | 31 | |
| Miscellaneous eating disorder NOS | NOS: not otherwise specified | 359 | 0% | 32 |
| Missing Cap | 823 | 0.1% | 6 | |
| Missing Labels | 466 | 0% | 68 | |
| Mixed Product | 242 | 0% | 24 | |
| Moist dermatitis | 1,320 | 0.1% | 35 | |
| Monocytopenia | 243 | 0% | 102 | |
| Monocytopenia | 224 | 0% | 0 | |
| Monocytosis | high monocyte count | 3,270 | 0.2% | 455 |
| Moribund | 219 | 0% | 8 | |
| Mouth pain | 264 | 0% | 19 | |
| Mucous stool | 2,204 | 0.2% | 105 | |
| Murmur | 894 | 0.1% | 6 | |
| Muscle atrophy | 516 | 0% | 127 | |
| Muscle shaking | 726 | 0.1% | 14 | |
| Muscle spasm NOS | NOS: not otherwise specified | 630 | 0.1% | 42 |
| Muscle stiffness | 1,059 | 0.1% | 30 | |
| Muscle tremor | 2,312 | 0.2% | 100 | |
| Muscle wasting | 1,044 | 0.1% | 120 | |
| Muscle weakness NOS | NOS: not otherwise specified | 859 | 0.1% | 87 |
| Musculoskeletal disorder NOS | NOS: not otherwise specified | 3,682 | 0.3% | 502 |
| Musculoskeletal pain | 2,013 | 0.2% | 36 | |
| Mydriasis | dilated pupils | 4,297 | 0.3% | 56 |
| Myoclonic jerk | 306 | 0% | 30 | |
| Myositis | 264 | 0% | 15 | |
| Nasal bleeding | 369 | 0% | 42 | |
| Nasal cavity and sinus disorder NOS | NOS: not otherwise specified | 217 | 0% | 3 |
| Nasal congestion | 353 | 0% | 33 | |
| Nasal discharge | 2,113 | 0.2% | 137 | |
| Nausea | 5,478 | 0.4% | 383 | |
| Necropsy performed | 973 | 0.1% | 376 | |
| Needlestick injury | 314 | 0% | 146 | |
| Neoplasia NOS | tumour, type not specified | 2,348 | 0.2% | 93 |
| Nephritis | 207 | 0% | 10 | |
| Neurological disorder NOS | NOS: not otherwise specified | 601 | 0% | 95 |
| Neurological signs NOS | NOS: not otherwise specified | 3,870 | 0.3% | 278 |
| Neurological symptoms NOS | NOS: not otherwise specified | 814 | 0.1% | 52 |
| Neutropenia | low neutrophil count | 2,727 | 0.2% | 405 |
| Neutrophilia | high neutrophil count | 6,910 | 0.5% | 658 |
| No sign | no clinical sign was reported | 11,326 | 0.8% | 28 |
| Non-regenerative anaemia | 687 | 0.1% | 122 | |
| Not drinking | 6,227 | 0.5% | 608 | |
| Not eating | 21,012 | 1.6% | 2,459 | |
| Not himself/herself | 3,198 | 0.2% | 858 | |
| Not sleeping | 1,296 | 0.1% | 152 | |
| Not urinating | 585 | 0% | 106 | |
| NT - Abnormal necropsy finding NOS | NOS: not otherwise specified | 1,262 | 0.1% | 0 |
| Nystagmus | rapid involuntary eye movement | 3,393 | 0.3% | 229 |
| Ocular discharge | 2,404 | 0.2% | 176 | |
| Odor, Abnormal | a product quality report, not a sign in an animal | 4,308 | 0.3% | 161 |
| Oedema NOS | NOS: not otherwise specified | 1,344 | 0.1% | 42 |
| Oedema of the extremities | swollen legs or paws | 1,692 | 0.1% | 21 |
| Off colour | 234 | 0% | 5 | |
| Oliguria | 300 | 0% | 22 | |
| Open mouth breathing | 814 | 0.1% | 86 | |
| Opisthotonus | 356 | 0% | 13 | |
| Oral bleeding | 1,012 | 0.1% | 38 | |
| Oral cavity disorder NOS | NOS: not otherwise specified | 475 | 0% | 40 |
| Oral mass | 238 | 0% | 23 | |
| Oral ulceration | 797 | 0.1% | 20 | |
| Other abnormal test result NOS | abnormal laboratory result, type not specified | 20,880 | 1.5% | 1,222 |
| Other blood disorder NOS | NOS: not otherwise specified | 268 | 0% | 27 |
| Other ear disorder NOS | NOS: not otherwise specified | 708 | 0.1% | 49 |
| Other immune system disorder NOS | NOS: not otherwise specified | 207 | 0% | 7 |
| Otitis externa | outer ear inflammation | 1,703 | 0.1% | 78 |
| Otitis NOS | NOS: not otherwise specified | 730 | 0.1% | 60 |
| Otorrhoea | 217 | 0% | 1 | |
| Overdose | more than the labelled amount was given | 14,309 | 1.1% | 1,227 |
| Pacing | 3,570 | 0.3% | 295 | |
| Paddling | 1,324 | 0.1% | 78 | |
| Pain NOS | NOS: not otherwise specified | 8,691 | 0.6% | 637 |
| Pale mucous membrane | pale gums | 8,433 | 0.6% | 454 |
| Pallor | 1,106 | 0.1% | 20 | |
| Palpable mass NOS | NOS: not otherwise specified | 615 | 0.1% | 14 |
| Palpebral disorder NOS | NOS: not otherwise specified | 204 | 0% | 23 |
| Pancreas disorder | 573 | 0% | 27 | |
| Pancreatitis | inflamed pancreas | 3,389 | 0.3% | 0 |
| Pancreatitis NOS | NOS: not otherwise specified | 761 | 0.1% | 315 |
| Panting | 15,139 | 1.1% | 1,234 | |
| Papilloma | 517 | 0% | 35 | |
| Papule | 648 | 0.1% | 16 | |
| Paraesthesia | 217 | 0% | 1 | |
| Paralysis | 791 | 0.1% | 61 | |
| Paralysis NOS | NOS: not otherwise specified | 364 | 0% | 60 |
| Paresis | 1,203 | 0.1% | 63 | |
| Partial anorexia | 638 | 0.1% | 93 | |
| Partial blindness | 527 | 0% | 8 | |
| Partial deafness | 1,312 | 0.1% | 41 | |
| Partial lack of efficacy | the product worked less well than expected | 3,275 | 0.2% | 534 |
| Patient instructions for use on label confusing | 647 | 0.1% | 120 | |
| Pawing | 354 | 0% | 50 | |
| Peeling skin | 340 | 0% | 14 | |
| Pericardial effusion | 361 | 0% | 31 | |
| Perinatal mortality NOS | NOS: not otherwise specified | 212 | 0% | 0 |
| Periorbital oedema | 628 | 0.1% | 52 | |
| Peripheral nervous system disorder NOS | NOS: not otherwise specified | 761 | 0.1% | 2 |
| Peritonitis | inflamed abdominal lining | 1,599 | 0.1% | 27 |
| Petechiae NOS | NOS: not otherwise specified | 386 | 0% | 34 |
| Physical label missing | 735 | 0.1% | 15 | |
| Pica NOS | eating non-food items | 2,251 | 0.2% | 153 |
| Pinnae disorder | 362 | 0% | 25 | |
| Pinnal erythema | 1,103 | 0.1% | 42 | |
| Pinnal irritation | 280 | 0% | 8 | |
| Pinnal oedema | 556 | 0% | 11 | |
| Pinnal reddening | 645 | 0.1% | 32 | |
| Platelet disorder NOS | NOS: not otherwise specified | 372 | 0% | 88 |
| Pleural effusion | 933 | 0.1% | 69 | |
| Pneumonia | lung infection or inflammation | 1,658 | 0.1% | 86 |
| Pododermatitis | 427 | 0% | 26 | |
| Pollakiuria | 243 | 0% | 20 | |
| Polycythaemia | 1,106 | 0.1% | 15 | |
| Polycythemia, relative | 347 | 0% | 0 | |
| Polydipsia | drinking more than usual | 14,258 | 1.1% | 847 |
| Polyphagia | 1,342 | 0.1% | 73 | |
| Polypnoea | fast breathing | 5,489 | 0.4% | 2 |
| Polyuria | passing more urine than usual | 11,054 | 0.8% | 804 |
| Poor coat condition | 228 | 0% | 18 | |
| Potency, Low | 597 | 0% | 17 | |
| PR-bone marrow, lesion(s) | legacy FDA term: lesions found in the bone marrow | 200 | 0% | 1 |
| PR-brain, lesion(s) | legacy FDA term: lesions found in the brain | 295 | 0% | 1 |
| PR-colon, lesion(s) | legacy FDA term: lesions found in the colon | 202 | 0% | 1 |
| PR-ear(s), lesion(s) | legacy FDA term: lesions found in the ears | 406 | 0% | 0 |
| PR-gi, lesion(s) | legacy FDA term: lesions found in the gi | 345 | 0% | 0 |
| PR-heart, lesion(s) | legacy FDA term: lesions found in the heart | 1,263 | 0.1% | 6 |
| PR-injection site, lesion(s) | legacy FDA term: lesions found in the injection site | 322 | 0% | 3 |
| PR-intest, lesion(s) | legacy FDA term: lesions found in the intest | 411 | 0% | 0 |
| PR-kidney(s), lesion(s) | legacy FDA term: lesions found in the kidneys | 1,482 | 0.1% | 1 |
| PR-liver, lesion(s) | legacy FDA term: lesions found in the liver | 3,247 | 0.2% | 7 |
| PR-lung(s), edema | 566 | 0% | 0 | |
| PR-lung(s), lesion(s) | legacy FDA term: lesions found in the lungs | 1,690 | 0.1% | 3 |
| PR-lymph node(s), lesion(s) | legacy FDA term: lesions found in the lymph nodes | 482 | 0% | 3 |
| PR-pancreas, lesion(s) | legacy FDA term: lesions found in the pancreas | 437 | 0% | 0 |
| PR-peritoneal effusion | 204 | 0% | 0 | |
| PR-skin, lesion(s) | legacy FDA term: lesions found in the skin | 1,287 | 0.1% | 11 |
| PR-small intestine, lesion(s) | legacy FDA term: lesions found in the small intestine | 745 | 0.1% | 0 |
| PR-spleen, lesion(s) | legacy FDA term: lesions found in the spleen | 777 | 0.1% | 3 |
| PR-stomach, lesion(s) | legacy FDA term: lesions found in the stomach | 855 | 0.1% | 0 |
| Precipitate, Sediment | a product quality report, not a sign in an animal | 1,323 | 0.1% | 177 |
| Product defect NOS | a product quality report, not a sign in an animal | 402 | 0% | 279 |
| Product Defect, General | a product quality report, not a sign in an animal | 9,310 | 0.7% | 1 |
| Product defect, product difficult to use/handle | a product quality report, not a sign in an animal | 1,914 | 0.1% | 930 |
| Product label issues | a product quality report, not a sign in an animal | 2,413 | 0.2% | 245 |
| Product problem | a product quality report, not a sign in an animal | 10,340 | 0.8% | 0 |
| Product syringe calibration unreadable | a product quality report, not a sign in an animal | 289 | 0% | 3 |
| Product syringe issue | a product quality report, not a sign in an animal | 1,470 | 0.1% | 98 |
| Product syringe missing | a product quality report, not a sign in an animal | 498 | 0% | 38 |
| Prolapse of the nictitating membrane | 434 | 0% | 10 | |
| Prolonged activated partial thrombin time (APTT) | 370 | 0% | 48 | |
| Prolonged anaesthesia | 203 | 0% | 5 | |
| Prolonged capillary refill time | 695 | 0.1% | 56 | |
| Prolonged one stage prothrombin time (OSPT) | 265 | 0% | 41 | |
| Proprioception abnormality | 1,153 | 0.1% | 47 | |
| Proprioception deficit | reduced awareness of limb position | 1,869 | 0.1% | 340 |
| Proprioception loss | 382 | 0% | 65 | |
| Proteinuria | protein in the urine | 5,133 | 0.4% | 515 |
| Pruritus | itching | 24,463 | 1.8% | 470 |
| Pulmonary congestion | 967 | 0.1% | 39 | |
| Pulmonary disorder NOS | NOS: not otherwise specified | 894 | 0.1% | 47 |
| Pulmonary neoplasm | 233 | 0% | 5 | |
| Pulmonary oedema | 1,022 | 0.1% | 91 | |
| Puncture wound | 209 | 0% | 0 | |
| Purulent lesion(s) | 354 | 0% | 55 | |
| Pustules | 953 | 0.1% | 35 | |
| Pyoderma | bacterial skin infection | 2,117 | 0.2% | 64 |
| Pyrexia | fever | 645 | 0.1% | 54 |
| Pyuria | 644 | 0.1% | 98 | |
| Quiet | 770 | 0.1% | 172 | |
| Rash | 3,386 | 0.3% | 114 | |
| Recovery prolonged | 1,444 | 0.1% | 38 | |
| Rectal bleeding | 834 | 0.1% | 35 | |
| Rectal prolapse | 207 | 0% | 14 | |
| Recumbency | lying down and unable or unwilling to rise | 7,088 | 0.5% | 157 |
| Red blood cell disorder | 465 | 0% | 21 | |
| Red blood cells(rbc) nucleated | 268 | 0% | 2 | |
| Red eye | 621 | 0.1% | 68 | |
| Reddening of the skin | 4,134 | 0.3% | 345 | |
| Reduced globulins | 1,036 | 0.1% | 82 | |
| Reduced responses | 926 | 0.1% | 55 | |
| Regenerative anaemia | 818 | 0.1% | 40 | |
| Regurgitation | 1,284 | 0.1% | 157 | |
| Reluctant to move | 5,537 | 0.4% | 415 | |
| Renal disorder NOS | kidney disorder, type not specified | 2,118 | 0.2% | 147 |
| Renal failure | kidney failure | 4,044 | 0.3% | 164 |
| Renal insufficiency | 378 | 0% | 23 | |
| Residues in meat/offal | 446 | 0% | 10 | |
| Residues in milk | 1,484 | 0.1% | 13 | |
| Respiratory arrest | 683 | 0.1% | 33 | |
| Respiratory distress | 1,789 | 0.1% | 90 | |
| Respiratory signs | 481 | 0% | 36 | |
| Respiratory sound | 745 | 0.1% | 20 | |
| Respiratory tract disorder NOS | NOS: not otherwise specified | 1,341 | 0.1% | 75 |
| Respiratory tract infection NOS | NOS: not otherwise specified | 421 | 0% | 51 |
| Restlessness | 9,243 | 0.7% | 432 | |
| Retching | 2,510 | 0.2% | 66 | |
| Retinal disorder NOS | NOS: not otherwise specified | 649 | 0.1% | 15 |
| Reverse sneezing | 306 | 0% | 31 | |
| Rigidity | 412 | 0% | 27 | |
| Rigidity of limbs | 277 | 0% | 26 | |
| Rolling | 525 | 0% | 62 | |
| Rubbing | 970 | 0.1% | 107 | |
| Ruminal bloat | 460 | 0% | 8 | |
| Scale | 622 | 0.1% | 30 | |
| Schirmer tear test | 200 | 0% | 0 | |
| Scleritis | 214 | 0% | 3 | |
| Scooting | 414 | 0% | 45 | |
| Scratching | 7,142 | 0.5% | 490 | |
| Seal, Abnormal | a product quality report, not a sign in an animal | 5,566 | 0.4% | 159 |
| Seborrhoea | 338 | 0% | 12 | |
| Sedation | 1,830 | 0.1% | 126 | |
| Sedation prolonged | 1,100 | 0.1% | 55 | |
| Seizure NOS | seizure, type not specified | 33,459 | 2.5% | 2,861 |
| Self mutilation | 272 | 0% | 11 | |
| Self trauma | 1,404 | 0.1% | 47 | |
| Sensory abnormality NOS | NOS: not otherwise specified | 452 | 0% | 3 |
| Septicaemia | 667 | 0.1% | 46 | |
| Shaking | 14,415 | 1.1% | 872 | |
| Shallow breathing | 426 | 0% | 49 | |
| Shivering | 1,428 | 0.1% | 88 | |
| Shock | 1,902 | 0.1% | 31 | |
| Sickness | 491 | 0% | 109 | |
| Skin abscess | 389 | 0% | 15 | |
| Skin and tissue infection NOS | NOS: not otherwise specified | 778 | 0.1% | 97 |
| Skin and/or appendage neoplasm NOS | NOS: not otherwise specified | 453 | 0% | 8 |
| Skin disorders NOS | NOS: not otherwise specified | 5,054 | 0.4% | 152 |
| Skin haematoma | 238 | 0% | 3 | |
| Skin haemorrhage NOS | NOS: not otherwise specified | 211 | 0% | 40 |
| Skin hyperaemia | reddened skin | 2,947 | 0.2% | 3 |
| Skin inflammation NOS | NOS: not otherwise specified | 1,005 | 0.1% | 98 |
| Skin irritation | 1,100 | 0.1% | 80 | |
| Skin lesion NOS | NOS: not otherwise specified | 5,861 | 0.4% | 322 |
| Skin lump | 1,582 | 0.1% | 66 | |
| Skin necrosis | 663 | 0.1% | 24 | |
| Skin petechiae | 1,024 | 0.1% | 19 | |
| Skin scab | 3,521 | 0.3% | 327 | |
| Skin slough | 1,019 | 0.1% | 0 | |
| Skin sore | 1,829 | 0.1% | 140 | |
| Skin swelling | 343 | 0% | 13 | |
| Skin tumour NOS | NOS: not otherwise specified | 354 | 0% | 11 |
| Skin ulcer | 1,251 | 0.1% | 108 | |
| Skin warmth | 400 | 0% | 21 | |
| Sleep disturbance NOS | NOS: not otherwise specified | 631 | 0.1% | 54 |
| Sleepiness - neurological disorder | 1,117 | 0.1% | 37 | |
| Sleepiness - systemic disorder | 1,664 | 0.1% | 260 | |
| Small intestine ulcer | 854 | 0.1% | 3 | |
| Small liver | 247 | 0% | 1 | |
| Smelly breath | 227 | 0% | 15 | |
| Sneezing | 2,160 | 0.2% | 133 | |
| Soft stool | 600 | 0% | 403 | |
| Solution, Abnormal | a product quality report, not a sign in an animal | 4,394 | 0.3% | 90 |
| Solution/Suspension, crystals | a product quality report, not a sign in an animal | 696 | 0.1% | 26 |
| Somnolence | 857 | 0.1% | 4 | |
| Spasm | 871 | 0.1% | 19 | |
| Spleen and reticulo-endothelial system disorder NOS | NOS: not otherwise specified | 400 | 0% | 18 |
| Splenic neoplasm | 580 | 0% | 0 | |
| Splenomegaly | 1,120 | 0.1% | 68 | |
| Spondylosis | 375 | 0% | 85 | |
| Squinting | 873 | 0.1% | 78 | |
| Staggering | 2,560 | 0.2% | 62 | |
| Star-gazing | 903 | 0.1% | 22 | |
| Staring | 1,531 | 0.1% | 275 | |
| Stiff gait | 591 | 0% | 58 | |
| Stiffness limb | 804 | 0.1% | 86 | |
| Stiffness NOS | NOS: not otherwise specified | 1,827 | 0.1% | 217 |
| Stillbirth | 417 | 0% | 3 | |
| Stomach upset | 1,265 | 0.1% | 128 | |
| Stomatitis | 494 | 0% | 9 | |
| Stopper, abnormal | 984 | 0.1% | 294 | |
| Strabismus | 218 | 0% | 23 | |
| Straining to defecate | 575 | 0% | 76 | |
| Stranguria | 537 | 0% | 38 | |
| Stress leukogram | 206 | 0% | 36 | |
| Stroke | 387 | 0% | 43 | |
| Stumbling gait | 2,582 | 0.2% | 239 | |
| Stupor | barely responsive | 1,692 | 0.1% | 16 |
| Sudden death | 1,265 | 0.1% | 56 | |
| Surgical site disorder | 487 | 0% | 22 | |
| Suspected infectious agent transmission | 418 | 0% | 0 | |
| Suspension, Abnormal | a product quality report, not a sign in an animal | 5,239 | 0.4% | 112 |
| Swallowing difficult | 302 | 0% | 23 | |
| Swelling around eye | 894 | 0.1% | 84 | |
| Swelling NOS | NOS: not otherwise specified | 1,955 | 0.1% | 107 |
| Swollen eye | 864 | 0.1% | 67 | |
| Swollen face | 483 | 0% | 30 | |
| Swollen feet | 334 | 0% | 28 | |
| Swollen limb | 730 | 0.1% | 142 | |
| Swollen lip | 516 | 0% | 35 | |
| Swollen lymph node | 405 | 0% | 23 | |
| Swollen mouth | 413 | 0% | 11 | |
| Swollen tongue | 328 | 0% | 23 | |
| Swollen vulva | 483 | 0% | 24 | |
| Syncope | 578 | 0% | 42 | |
| Syringe, Abnormal | a product quality report, not a sign in an animal | 564 | 0% | 26 |
| Systemic disorder NOS | NOS: not otherwise specified | 2,968 | 0.2% | 72 |
| Tablets, Abnormal | a product quality report, not a sign in an animal | 19,589 | 1.4% | 1,201 |
| Tachycardia | fast heart rate | 6,765 | 0.5% | 338 |
| Tachypnoea | fast breathing | 4,666 | 0.3% | 207 |
| Tarry or black stool | 1,401 | 0.1% | 87 | |
| Temporary blindness | 890 | 0.1% | 19 | |
| Temporary deafness | 647 | 0.1% | 8 | |
| Tenesmus | 645 | 0.1% | 14 | |
| Tense abdomen | 1,263 | 0.1% | 144 | |
| Third eyelid protrusion | 804 | 0.1% | 113 | |
| Thrombocytopenia | low platelet count | 7,338 | 0.5% | 309 |
| Thrombocytosis | high platelet count | 1,749 | 0.1% | 198 |
| Tiredness | 1,459 | 0.1% | 156 | |
| Tongue disorder NOS | NOS: not otherwise specified | 803 | 0.1% | 56 |
| Tongue oedema | 452 | 0% | 0 | |
| Tongue protrusion | 514 | 0% | 43 | |
| Tongue ulceration | 474 | 0% | 22 | |
| Tonic-clonic seizure | 286 | 0% | 17 | |
| Tooth disorder | 698 | 0.1% | 42 | |
| Torn ligament | 237 | 0% | 50 | |
| Toxicity | 202 | 0% | 0 | |
| Trauma NOS | NOS: not otherwise specified | 796 | 0.1% | 19 |
| Trembling | 12,544 | 0.9% | 282 | |
| Tremor | 8,028 | 0.6% | 679 | |
| Tremor of limb | 705 | 0.1% | 64 | |
| Tubes, Abnormal | a product quality report, not a sign in an animal | 2,078 | 0.2% | 73 |
| Tubes, Damaged | a product quality report, not a sign in an animal | 1,419 | 0.1% | 89 |
| Tubes, Leaking | a product quality report, not a sign in an animal | 5,199 | 0.4% | 287 |
| Twitching | 6,998 | 0.5% | 354 | |
| Tympanic rupture | 237 | 0% | 26 | |
| Ulceration NOS | NOS: not otherwise specified | 659 | 0.1% | 40 |
| Ulcerative dermatitis | 234 | 0% | 19 | |
| Ultrasound, liver abnormal | 1,362 | 0.1% | 7 | |
| Unable to jump | 699 | 0.1% | 114 | |
| Unable to rise | 1,488 | 0.1% | 145 | |
| Unable to stand | 3,722 | 0.3% | 402 | |
| Unable to walk | 1,485 | 0.1% | 571 | |
| Unclassifiable adverse event | event that fits no dictionary term | 10,311 | 0.8% | 175 |
| Uncoded sign | a sign with no matching dictionary term | 10,160 | 0.8% | 12 |
| Uncomfortable | 1,734 | 0.1% | 260 | |
| Unconscious | 336 | 0% | 32 | |
| Underdose | less than the labelled amount was given | 11,005 | 0.8% | 733 |
| Underfilling, Bottles | a product quality report, not a sign in an animal | 1,338 | 0.1% | 87 |
| Underfilling, Container | a product quality report, not a sign in an animal | 6,245 | 0.5% | 541 |
| Underfilling, Package | a product quality report, not a sign in an animal | 10,640 | 0.8% | 296 |
| Underfilling, Tubes | a product quality report, not a sign in an animal | 7,258 | 0.5% | 188 |
| Underfilling, Vials | a product quality report, not a sign in an animal | 1,452 | 0.1% | 40 |
| Unexplained death | 562 | 0% | 38 | |
| Unpalatable | legacy FDA term: the animal would not take it | 28,240 | 2.1% | 866 |
| Unrelated death | 676 | 0.1% | 58 | |
| Unresponsive to stimuli | 1,695 | 0.1% | 167 | |
| Unsteady gait | 1,607 | 0.1% | 180 | |
| Unusual stool colour | 242 | 0% | 23 | |
| Unwell | 695 | 0.1% | 272 | |
| Urinary bladder disorder NOS | NOS: not otherwise specified | 689 | 0.1% | 69 |
| Urinary incontinence | 6,097 | 0.5% | 604 | |
| Urinary retention | 460 | 0% | 57 | |
| Urinary tract disorder NOS | NOS: not otherwise specified | 1,840 | 0.1% | 42 |
| Urinary tract infection | 5,156 | 0.4% | 564 | |
| Urination | 908 | 0.1% | 32 | |
| Urination related to convulsion | 391 | 0% | 86 | |
| Urine abnormalities NOS | NOS: not otherwise specified | 2,035 | 0.2% | 184 |
| Urine leakage | 670 | 0.1% | 71 | |
| Urolithiasis | 337 | 0% | 25 | |
| Urticaria | hives | 5,768 | 0.4% | 33 |
| Uveitis | 456 | 0% | 33 | |
| Vaginal discharge | 292 | 0% | 25 | |
| Vaginal haemorrhage | 217 | 0% | 11 | |
| Vaginal swelling | 206 | 0% | 3 | |
| Vasculitis | 436 | 0% | 34 | |
| Vesicle | 392 | 0% | 4 | |
| Vestibular disorder NOS | NOS: not otherwise specified | 2,001 | 0.2% | 203 |
| Vials, Abnormal | a product quality report, not a sign in an animal | 1,125 | 0.1% | 36 |
| Vials, Damaged | a product quality report, not a sign in an animal | 3,115 | 0.2% | 180 |
| Vials, Leaking | a product quality report, not a sign in an animal | 5,451 | 0.4% | 41 |
| Vocalisation | crying out or unusual noise | 14,106 | 1% | 735 |
| Vomiting | 213,494 | 15.7% | 8,157 | |
| Vomiting bile | 715 | 0.1% | 202 | |
| Walking difficulty | 4,812 | 0.4% | 409 | |
| Warm feeling to the touch | 693 | 0.1% | 102 | |
| Wbc, urine | 875 | 0.1% | 0 | |
| Weak pulse | 637 | 0.1% | 95 | |
| Weakness | 10,660 | 0.8% | 656 | |
| Weight fluctuation | 378 | 0% | 54 | |
| Weight gain | 6,660 | 0.5% | 347 | |
| Weight loss | 24,015 | 1.8% | 1,996 | |
| Welt | 473 | 0% | 40 | |
| Wheezing | 1,082 | 0.1% | 69 | |
| Whining | 561 | 0% | 148 | |
| Wobbliness | 1,397 | 0.1% | 501 | |
| Wound | 1,048 | 0.1% | 188 | |
| Wrong technique in drug usage process | 373 | 0% | 2 |